UNSPSC 51452101: Hexylresorcinol

This classification denotes a topical anti-infective agent with the molecular formula C12H18O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R9QTB5E82N, chemically known as 1,3-dihydroxy-4-n-hexylbenzene but generally known as 4-hexylresorcinol, which bears US NIH Compound Identifier 3610. European Medicines Agency schedules Hexylresorcinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14103MIG.

World Health Organization schedules 4-hexylresorcinol in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, HEXYLRESORCINOL remains the US FDA Preferred Term for this commodity. Hexylresorcinol bears US NLM identifiers UMLS ID C0019497 and NCI Concept Code C29092. SMILES: CCCCCCC1=C(C=C(C=C1)O)O.

UNSPSC 51452101 Hexylresorcinol is a Commodity code whose recent state and local activity centers on pharmaceutical procurement spanning naloxone systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals distributed through authorized wholesalers. The code shows activity across state health and human services departments, county health systems, municipal fire departments, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. Issuing bodies range from individual county health departments (Seminole County, Florida) to state-level agencies (Texas Health and Human Services Commission, Minnesota Department of Administration) and municipal purchasing offices (City of Tampa). The work being solicited includes acquisition of emergency pharmaceutical products, establishment of direct contracting relationships with pharmaceutical manufacturers, procurement of medical consumables for first responder use, and management of statewide or regional pharmaceutical supply agreements with defined wholesaler networks and pricing models.

Recent opportunities reflect geographic concentration in the Southeast and Upper Midwest. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries; the City of Tampa issued IFB 26P00145 on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; the Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) effective July 1, 2026; and the Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 as a market intelligence tool to explore direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization arrangements.